News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vivalis and Kaketsuken Extend their Collaboration in the Tetsing of Vivalis EBx(R) Cells



1/29/2008 12:21:12 PM

NANTES, FRANCE and KUMAMOTO, JAPAN--(Marketwire - January 29, 2008) - VIVALIS AND KAKETSUKEN EXTEND THEIR COLLABORATION IN THE TESTING OF VIVALIS EBx® CELLS FOR THE PRODUCTION OF HUMAN AND VETERINARY VIRAL VACCINE. VIVALIS and THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE (KAKETSUKEN) announced today that they have extended the research licence to 2 new viruses, one in the field of human disease, the other in the veterinary field.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES